Correction to Lancet Rheumatol 2021; 3: e789-97

No authors listed

Published Erratum

No authors listed. Lancet Rheumatol. 2022 Mar.

. 2022 Mar;4(3):e174.

doi: 10.1016/S2665-9913(22)00025-X. Epub 2022 Jan 20.

Abstract

[This corrects the article DOI: 10.1016/S2665-9913(21)00251-4.].

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study.
Moor MB, Suter-Riniker F, Horn MP, Aeberli D, Amsler J, Möller B, Njue LM, Medri C, Angelillo-Scherrer A, Borradori L, Radonjic-Hoesli S, Seyed Jafari SM, Chan A, Hoepner R, Bacher VU, Mani LY, Iype JM, Hirzel C, Maurer B, Sidler D. Moor MB, et al. Lancet Rheumatol. 2021 Nov;3(11):e789-e797. doi: 10.1016/S2665-9913(21)00251-4. Epub 2021 Sep 7. Lancet Rheumatol. 2021. PMID: 34514436 Free PMC article.